Shares of Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) have received an average recommendation of “Reduce” from the eight ratings firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating and seven have issued a hold rating on the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $17.25.
A number of analysts have issued reports on SLP shares. Weiss Ratings raised shares of Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday. Craig Hallum cut shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 target price on the stock. in a report on Thursday, June 18th. William Blair downgraded shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 17th. TD Cowen dropped their price target on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 10th. Finally, Wall Street Zen cut Simulations Plus from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th.
View Our Latest Analysis on Simulations Plus
Simulations Plus Stock Performance
Simulations Plus (NASDAQ:SLP – Get Free Report) last released its quarterly earnings results on Thursday, July 9th. The technology company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.23 by $0.07. Simulations Plus had a net margin of 9.88% and a return on equity of 13.50%. The business had revenue of $21.89 million for the quarter, compared to the consensus estimate of $20.90 million. On average, equities research analysts predict that Simulations Plus will post 0.8 earnings per share for the current fiscal year.
Insider Activity at Simulations Plus
In related news, Director Walter S. Woltosz sold 4,177 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $18.44, for a total value of $77,023.88. Following the transaction, the director owned 3,202,131 shares in the company, valued at approximately $59,047,295.64. This trade represents a 0.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 19.10% of the company’s stock.
Institutional Investors Weigh In On Simulations Plus
A number of large investors have recently bought and sold shares of SLP. GAMMA Investing LLC increased its holdings in Simulations Plus by 26.0% in the 2nd quarter. GAMMA Investing LLC now owns 2,831 shares of the technology company’s stock valued at $52,000 after buying an additional 585 shares during the period. Bank of America Corp DE raised its position in shares of Simulations Plus by 13.2% in the 1st quarter. Bank of America Corp DE now owns 188,417 shares of the technology company’s stock valued at $2,227,000 after buying an additional 21,994 shares in the last quarter. Royal Bank of Canada lifted its holdings in shares of Simulations Plus by 19.4% during the 1st quarter. Royal Bank of Canada now owns 30,414 shares of the technology company’s stock worth $359,000 after acquiring an additional 4,947 shares during the period. Quantinno Capital Management LP lifted its holdings in shares of Simulations Plus by 439.1% during the 1st quarter. Quantinno Capital Management LP now owns 112,259 shares of the technology company’s stock worth $1,327,000 after acquiring an additional 91,434 shares during the period. Finally, First Light Asset Management LLC boosted its position in shares of Simulations Plus by 33.7% during the 1st quarter. First Light Asset Management LLC now owns 2,632,823 shares of the technology company’s stock worth $31,120,000 after acquiring an additional 663,906 shares in the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.
About Simulations Plus
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.
Featured Articles
- Five stocks we like better than Simulations Plus
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
